Alaris Royalty Corp.
TSX : AD

Alaris Royalty Corp.

April 21, 2009 12:04 ET

Alaris Announces Better Than Expected Growth From Two Royalties

CALGARY, ALBERTA--(Marketwire - April 21, 2009) - Alaris Royalty Corp. (TSX:AD) ("Alaris" or the "Corporation") is pleased to report that the annual adjustments to two of our investments, LifeMark Health and MEDIchair have come in higher than anticipated.

LifeMark Health reported a same clinic sales increase of 5.63% for their fiscal year ending December 31, 2008 compared to an increase of 3.10% for the prior year. This results in Alaris's cash distribution from LifeMark increasing from $7,465,464 to $7,885,768, an increase in revenue for Alaris of more than $420,000 for 2009. "LifeMark continues to show tremendous stability even in these difficult economic conditions, recording their highest ever same clinic sales results" commented Alaris President and CEO Steve King. "This not only demonstrates the stability of the industry but also the excellent management team at LifeMark."

MEDIchair also reported excellent same store sales results for their 2008 operating year, reporting an increase of 4.12%. This is MEDIchair's 20th consecutive year of same store sales increases. "MEDIchair continues to benefit from the strong demographic trend of an aging population as well as a very well conceived business strategy" King said. The increase in Alaris's royalty from MEDIchair will result in a revenue increase for Alaris of more than $46,000 in 2009 compared to 2008.

About the Corporation:

The Corporation provides alternative financing for a diversified group of private businesses ("Finance Group Members") in exchange for royalties or distributions from the Finance Group Members, with the principal objective of generating stable and predictable cash flows for dividend payments to its shareholders. Royalties or distributions from the Finance Group Members are structured as a percentage of a "top line" financial performance measure such as gross margin and same-store sales and rank in priority to the owners' common equity position.

Contact Information

  • Alaris Royalty Corp.
    Curtis Krawetz
    Investor Relations
    (403) 221-7305